BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 22743594)

  • 1. The kinetic mechanism of S. pneumoniae DNA ligase and inhibition by adenosine-based antibacterial compounds.
    Jahić H; Liu CF; Thresher J; Livchak S; Wang H; Ehmann DE
    Biochem Pharmacol; 2012 Sep; 84(5):654-60. PubMed ID: 22743594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of bacterial NAD+-dependent DNA ligase inhibitors: optimization of antibacterial activity.
    Stokes SS; Huynh H; Gowravaram M; Albert R; Cavero-Tomas M; Chen B; Harang J; Loch JT; Lu M; Mullen GB; Zhao S; Liu CF; Mills SD
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4556-60. PubMed ID: 21719282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of an inhibitor specific to bacterial NAD+-dependent DNA ligases.
    Meier TI; Yan D; Peery RB; McAllister KA; Zook C; Peng SB; Zhao G
    FEBS J; 2008 Nov; 275(21):5258-71. PubMed ID: 18795946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification through structure-based methods of a bacterial NAD(+)-dependent DNA ligase inhibitor that avoids known resistance mutations.
    Murphy-Benenato K; Wang H; McGuire HM; Davis HE; Gao N; Prince DB; Jahic H; Stokes SS; Boriack-Sjodin PA
    Bioorg Med Chem Lett; 2014 Jan; 24(1):360-6. PubMed ID: 24287382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Streptococcus pneumononiae gyrase ATPase: development and validation of an assay for inhibitor discovery and characterization.
    Miller JR; Herberg JT; Tomilo M; McCroskey MC; Feilmeier BJ
    Anal Biochem; 2007 Jun; 365(1):132-43. PubMed ID: 17395144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of bacterial NAD⁺-dependent DNA ligase inhibitors: improvements in clearance of adenosine series.
    Stokes SS; Gowravaram M; Huynh H; Lu M; Mullen GB; Chen B; Albert R; O'Shea TJ; Rooney MT; Hu H; Newman JV; Mills SD
    Bioorg Med Chem Lett; 2012 Jan; 22(1):85-9. PubMed ID: 22154350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A high-throughput fluorescence resonance energy transfer-based assay for DNA ligase.
    Shapiro AB; Eakin AE; Walkup GK; Rivin O
    J Biomol Screen; 2011 Jun; 16(5):486-93. PubMed ID: 21398623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel bacterial NAD+-dependent DNA ligase inhibitors with broad-spectrum activity and antibacterial efficacy in vivo.
    Mills SD; Eakin AE; Buurman ET; Newman JV; Gao N; Huynh H; Johnson KD; Lahiri S; Shapiro AB; Walkup GK; Yang W; Stokes SS
    Antimicrob Agents Chemother; 2011 Mar; 55(3):1088-96. PubMed ID: 21189350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NAD+-dependent DNA ligase (Rv3014c) from Mycobacterium tuberculosis: novel structure-function relationship and identification of a specific inhibitor.
    Srivastava SK; Dube D; Kukshal V; Jha AK; Hajela K; Ramachandran R
    Proteins; 2007 Oct; 69(1):97-111. PubMed ID: 17557328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of the first inhibitors of bacterial enzyme D-aspartate ligase from Enterococcus faecium (Aslfm).
    Škedelj V; Perdih A; Brvar M; Kroflič A; Dubbée V; Savage V; O'Neill AJ; Solmajer T; Bešter-Rogač M; Blanot D; Hugonnet JE; Magnet S; Arthur M; Mainardi JL; Stojan J; Zega A
    Eur J Med Chem; 2013 Sep; 67():208-20. PubMed ID: 23867605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and Optimization of NAD+-Dependent DNA Ligase Inhibitors as Novel Antibacterial Compounds.
    Bi F; Ma R; Ma S
    Curr Pharm Des; 2017; 23(14):2117-2130. PubMed ID: 27784238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydropteroate synthase from Streptococcus pneumoniae: characterization of substrate binding order and sulfonamide inhibition.
    Vinnicombe HG; Derrick JP
    Biochem Biophys Res Commun; 1999 May; 258(3):752-7. PubMed ID: 10329458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A high-throughput assay for the adenylation reaction of bacterial DNA ligase.
    Miesel L; Kravec C; Xin AT; McMonagle P; Ma S; Pichardo J; Feld B; Barrabee E; Palermo R
    Anal Biochem; 2007 Jul; 366(1):9-17. PubMed ID: 17493575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific and potent inhibition of NAD+-dependent DNA ligase by pyridochromanones.
    Brötz-Oesterhelt H; Knezevic I; Bartel S; Lampe T; Warnecke-Eberz U; Ziegelbauer K; Häbich D; Labischinski H
    J Biol Chem; 2003 Oct; 278(41):39435-42. PubMed ID: 12867414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a fluorescence resonance energy transfer assay for measuring the activity of Streptococcus pneumoniae DNA ligase, an enzyme essential for DNA replication, repair, and recombination.
    Chen XC; Hentz NG; Hubbard F; Meier TI; Sittampalam S; Zhao G
    Anal Biochem; 2002 Oct; 309(2):232-40. PubMed ID: 12413456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of NAD(+) -dependent DNA ligase of mycobacteria as a potential target for antibiotics.
    Korycka-Machala M; Rychta E; Brzostek A; Sayer HR; Rumijowska-Galewicz A; Bowater RP; Dziadek J
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2888-97. PubMed ID: 17548501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of deletion and site-directed mutations on ligation steps of NAD+-dependent DNA ligase: a biochemical analysis of BRCA1 C-terminal domain.
    Feng H; Parker JM; Lu J; Cao W
    Biochemistry; 2004 Oct; 43(39):12648-59. PubMed ID: 15449954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of potent NAD+-dependent DNA ligase inhibitors as potential antibacterial agents. Part I: aminoalkoxypyrimidine carboxamides.
    Gu W; Wang T; Maltais F; Ledford B; Kennedy J; Wei Y; Gross CH; Parsons J; Duncan L; Arends SJ; Moody C; Perola E; Green J; Charifson PS
    Bioorg Med Chem Lett; 2012 Jun; 22(11):3693-8. PubMed ID: 22560473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacterium tuberculosis NAD+-dependent DNA ligase is selectively inhibited by glycosylamines compared with human DNA ligase I.
    Srivastava SK; Dube D; Tewari N; Dwivedi N; Tripathi RP; Ramachandran R
    Nucleic Acids Res; 2005; 33(22):7090-101. PubMed ID: 16361267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tricyclic dihydrobenzoxazepine and tetracyclic indole derivatives can specifically target bacterial DNA ligases and can distinguish them from human DNA ligase I.
    Yadav N; Khanam T; Shukla A; Rai N; Hajela K; Ramachandran R
    Org Biomol Chem; 2015 May; 13(19):5475-87. PubMed ID: 25875403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.